Nature (London), 2011-04, Vol.472 (7344), p.491-494
2011
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand
- Ist Teil von
- Nature (London), 2011-04, Vol.472 (7344), p.491-494
- Ort / Verlag
- London: Nature Publishing Group
- Erscheinungsjahr
- 2011
- Quelle
- EBSCOhost Psychology and Behavioral Sciences Collection
- Beschreibungen/Notizen
- T-helper cells that produce interleukin-17 (T(H)17 cells) are a recently identified CD4(+) T-cell subset with characterized pathological roles in autoimmune diseases. The nuclear receptors retinoic-acid-receptor-related orphan receptors α and γt (RORα and RORγt, respectively) have indispensible roles in the development of this cell type. Here we present SR1001, a high-affinity synthetic ligand-the first in a new class of compound-that is specific to both RORα and RORγt and which inhibits T(H)17 cell differentiation and function. SR1001 binds specifically to the ligand-binding domains of RORα and RORγt, inducing a conformational change within the ligand-binding domain that encompasses the repositioning of helix 12 and leads to diminished affinity for co-activators and increased affinity for co-repressors, resulting in suppression of the receptors' transcriptional activity. SR1001 inhibited the development of murine T(H)17 cells, as demonstrated by inhibition of interleukin-17A gene expression and protein production. Furthermore, SR1001 inhibited the expression of cytokines when added to differentiated murine or human T(H)17 cells. Finally, SR1001 effectively suppressed the clinical severity of autoimmune disease in mice. Our data demonstrate the feasibility of targeting the orphan receptors RORα and RORγt to inhibit specifically T(H)17 cell differentiation and function, and indicate that this novel class of compound has potential utility in the treatment of autoimmune diseases.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-0836eISSN: 1476-4687DOI: 10.1038/nature10075Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3148894
- Format
- –
- Schlagworte
- Animals, Autoimmunity - drug effects, Autoimmunity - immunology, Biological and medical sciences, Cell Differentiation - drug effects, Drug Inverse Agonism, Fundamental and applied biological sciences. Psychology, Fundamental immunology, Genetics of the immune response, HEK293 Cells, Humans, Immunobiology, Interleukin-17 - biosynthesis, Interleukin-17 - immunology, Interleukins - biosynthesis, Interleukins - immunology, Ligands, Mice, Mice, Inbred C57BL, Models, Molecular, Nuclear Receptor Subfamily 1, Group F, Member 1 - antagonists & inhibitors, Nuclear Receptor Subfamily 1, Group F, Member 1 - genetics, Nuclear Receptor Subfamily 1, Group F, Member 1 - metabolism, Nuclear Receptor Subfamily 1, Group F, Member 3 - antagonists & inhibitors, Nuclear Receptor Subfamily 1, Group F, Member 3 - genetics, Nuclear Receptor Subfamily 1, Group F, Member 3 - metabolism, Sulfonamides - pharmacology, Th17 Cells - cytology, Th17 Cells - drug effects, Th17 Cells - immunology, Th17 Cells - secretion, Thiazoles - pharmacology